Browsing Tag

Adaptive Biotechnologies

Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

James Pereira Dec 28, 2022

SEATTLE, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq:…
Read More...

James Pereira Nov 22, 2022

SEATTLE, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq:…
Read More...

James Pereira Oct 11, 2022

SEATTLE, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
Read More...

James Pereira Feb 20, 2022

Data being presented at the 17th European Crohn’s and Colitis Organisation (ECCO) exhibit the use of Adaptive’s…
Read More...

James Pereira Dec 14, 2021

Analysis of the MASTER trial (Abstract 481) showed clonoSEQ’s ability to measure deep and durable responses and permit…
Read More...

James Pereira Nov 12, 2021

Local coverage determination (LCD) confirms access to the only FDA-cleared in vitro diagnostic to detect and monitor…
Read More...

James Pereira Oct 2, 2021

Real-world data show T-Detect™ COVID can detect prior SARS-CoV-2 infection nearly 12 months after initial diagnosis in…
Read More...

James Pereira Jul 13, 2021

SEATTLE, July 12, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
Read More...